ID: ALA5199175

Max Phase: Preclinical

Molecular Formula: C31H28FN3O5S

Molecular Weight: 573.65

Associated Items:

Representations

Canonical SMILES:  O=C(NCc1ccccc1C(=O)N[C@H](/C=C(\F)S(=O)(=O)Oc1ccccc1)CCc1ccccc1)c1ccncc1

Standard InChI:  InChI=1S/C31H28FN3O5S/c32-29(41(38,39)40-27-12-5-2-6-13-27)21-26(16-15-23-9-3-1-4-10-23)35-31(37)28-14-8-7-11-25(28)22-34-30(36)24-17-19-33-20-18-24/h1-14,17-21,26H,15-16,22H2,(H,34,36)(H,35,37)/b29-21+/t26-/m0/s1

Standard InChI Key:  PUBPSDVGKSFNGZ-MUXFTLNZSA-N

Associated Targets(Human)

Cathepsin L 3852 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cathepsin B 3822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rhodesain 1463 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Trypanosoma brucei brucei 13300 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

J774.1 238 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 573.65Molecular Weight (Monoisotopic): 573.1734AlogP: 4.96#Rotatable Bonds: 12
Polar Surface Area: 114.46Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.40CX LogP: 5.53CX LogD: 5.53
Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.23Np Likeness Score: -0.64

References

1. Jung S, Fuchs N, Grathwol C, Hellmich UA, Wagner A, Diehl E, Willmes T, Sotriffer C, Schirmeister T..  (2022)  New peptidomimetic rhodesain inhibitors with improved selectivity towards human cathepsins.,  238  [PMID:35597010] [10.1016/j.ejmech.2022.114460]

Source